本页面由Tiger Trade Technology Pte. Ltd.提供服务

Inhibrx Biosciences

88.45
-2.0800-2.30%
成交量:18.60万
成交额:1,642.53万
市值:12.98亿
市盈率:-9.96
高:92.46
开:90.11
低:85.80
收:90.53
52周最高:155.29
52周最低:28.16
股本:1,467.12万
流通股本:858.89万
量比:1.09
换手率:2.17%
股息:- -
股息率:- -
每股收益(TTM):-8.8768
每股收益(LYR):-9.0434
净资产收益率:-1773.60%
总资产收益率:-43.61%
市净率:-24.49
市盈率(LYR):-9.78

数据加载中...

2024/03/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/28

重要事件披露

Form 8-K - Current report
2024/02/28

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/15

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/15

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/23

重要事件披露

Form 8-K - Current report
2023/11/10

重要事件披露

Form 8-K - Current report
2023/11/10

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/02

重要事件披露

Form 8-K - Current report
2023/09/20

重要事件披露

Form 8-K - Current report
2023/08/29

重要事件披露

Form 8-K - Current report
2023/08/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/07

重要事件披露

Form 8-K - Current report
2023/05/30

重要事件披露

Form 8-K - Current report